Antiva Biosciences Overview
- Founded
- 2012

- Status
- Private
- Employees
- 17

- Latest Deal Type
- Series D
- Latest Deal Amount
- $31M

- Investors
- 18
Antiva Biosciences General Information
Description
Developer of small molecule antivirals designed to improve health outcomes for patients suffering from diseases caused by HPV and other viruses. The company's medicinal chemistry platform focuses on the development and commercialization of direct-acting antivirals for infections with the human papillomavirus, herpes group viruses, HIV, and animal retroviruses, enabling patients to recover from HPV-related diseases and other viruses.
Contact Information
- 280 Old County Road
- Suite 257
- Brisbane, CA 94005
- United States
Antiva Biosciences Timeline
Antiva Biosciences Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
8. Later Stage VC (Series D) | 02-Nov-2021 | $31M | 000.00 | 0000 | Completed | Generating Revenue |
7. Later Stage VC (Series C1) | 10-Jul-2018 | 0000 | 000.00 | 0000 | Completed | Generating Revenue |
6. Later Stage VC (Series C) | 24-Jan-2018 | 000.00 | 000.00 | 000.00 | Completed | Generating Revenue |
5. Early Stage VC (Series B1) | 27-May-2015 | 0000 | 0000 | 000.00 | Completed | Generating Revenue |
4. Early Stage VC | 22-Dec-2014 | 00.000 | 00.000 | 000.00 | Completed | Startup |
3. Debt - General | 09-Jul-2014 | 00.00 | 00.000 | Completed | Startup | |
2. Early Stage VC | 05-Sep-2013 | $1.13M | $1.13M | 00.00 | Completed | Startup |
1. Accelerator/Incubator | Completed | Startup |
Antiva Biosciences Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series D | 00,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
Series C1 | 00,000,000 | 00.000000 | 00.0 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
Series C | 00,000,000 | 00.000000 | 00.00 | 00 | 00 | 00 | 00.00 | 00.000 |
Series B1 | 13,723,579 | $0.001000 | $0.07 | $0.9 | $0.9 | 1x | $0.73 | 11.74% |
Series A | 1,635,718 | $0.001000 | $0.06 | $0.7 | $0.7 | 1x | $0.63 | 1.27% |
Antiva Biosciences Comparisons
Industry
00000000
000000 0
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialAntiva Biosciences Competitors (85)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
NexImmune | Formerly VC-backed | Gaithersburg, MD | 00 | 00000 | 00000000 | 00000 |
000000 00000000000 | Formerly VC-backed | Boston, MA | 0000 | 00.000 | 000000&0 | |
000000000 00000000 | Venture Capital-Backed | Rockville, MD | 0 | 000.00 | 0000000000 0 | 000.00 |
00000000 000000000 | Formerly VC-backed | San Diego, CA | 000 | 00000 | 000000000 - | 00000 |
0000000 0000000000 | Venture Capital-Backed | Niel, Belgium | 00 | 000.00 | 00000000000 | 000.00 |
Antiva Biosciences Executive Team (7)
Antiva Biosciences Board Members (10)
Name | Representing | Role | Since |
---|---|---|---|
Benjamin Rovinski Ph.D | Lumira Ventures | Board Member | 000 0000 |
Clifford Samuel | Self | Board Member | 000 0000 |
David Kabakoff Ph.D | Sofinnova Investments | Board Member | 000 0000 |
Jenny Yip | Adjuvant Capital | Board Member | 000 0000 |
Michael Cannon | Self | Board Member | 000 0000 |
Antiva Biosciences Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialAntiva Biosciences Investors (18)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Adjuvant Capital | Impact Investing | Minority | 000 0000 | 000000 0 | |
Avestria Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | |
Dong-A ST Company | Corporation | Minority | 000 0000 | 000000 0 | |
Gaingels | Venture Capital | Minority | 000 0000 | 000000 0 | |
GV | Corporate Venture Capital | Minority | 000 0000 | 000000 0 |